Ovarian cancer classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
(50 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
<div style="-webkit-user-select: none;"> | |||
{|class="infobox" style="position: fixed; top: 65%; right: 10px; margin: 0 0 0 0; border: 0; float: right; | |||
|- | |||
| {{#ev:youtube|https://https://www.youtube.com/watch?v=h8WqX5VQP88|350}} | |||
|- | |||
|} | |||
{{Ovarian cancer}} | {{Ovarian cancer}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{Hudakarman}} | ||
==Overview== | ==Overview== | ||
Ovarian cancer | [[Ovarian cancer]] may be classified according to the [[histology]] of the [[tumor]], obtained in a [[pathology]] report. Based on the classification, the management of ovarian cancer is directed and determined. The main four types of ovarian cancer are [[Surface epithelial-stromal tumour]], [[Sex cord-stromal tumour|Sex cord-stromal tumor]], [[Germ cell tumor]], and Mixed tumors. | ||
==Classification== | ==Classification== | ||
Histology dictates many aspects of clinical treatment, management, and [[prognosis]]. | *Histology dictates many aspects of clinical treatment, management, and [[prognosis]].<ref name="pmid11385772">{{cite journal| author=Heintz AP, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman WT et al.| title=Carcinoma of the ovary. | journal=J Epidemiol Biostat | year= 2001 | volume= 6 | issue= 1 | pages= 107-38 | pmid=11385772 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11385772 }} </ref><ref name="pmid21340753">{{cite journal| author=Banks E| title=The epidemiology of ovarian cancer. | journal=Methods Mol Med | year= 2001 | volume= 39 | issue= | pages= 3-11 | pmid=21340753 | doi=10.1385/1-59259-071-3:3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21340753 }} </ref><ref name="pmid12644542">{{cite journal| author=Singer G, Oldt R, Cohen Y, Wang BG, Sidransky D, Kurman RJ et al.| title=Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. | journal=J Natl Cancer Inst | year= 2003 | volume= 95 | issue= 6 | pages= 484-6 | pmid=12644542 | doi=10.1093/jnci/95.6.484 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12644542 }} </ref><ref name="pmid15644779">{{cite journal| author=Singer G, Stöhr R, Cope L, Dehari R, Hartmann A, Cao DF et al.| title=Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation. | journal=Am J Surg Pathol | year= 2005 | volume= 29 | issue= 2 | pages= 218-24 | pmid=15644779 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15644779 }} </ref> | ||
**[[Surface epithelial-stromal tumor]], including serous and mucinous [[cystadenocarcinoma]], is the most common type of ovarian cancer. | |||
**[[Sex cord-stromal tumour|Sex cord-stromal tumor]], including [[estrogen]]-producing [[granulosa cell tumor]] and '''virilizing''' [[Sertoli-Leydig cell tumor]] or [[arrhenoblastoma]], accounts for 8% of ovarian cancers. | |||
**[[Germ cell tumor]] accounts for approximately 5% of ovarian cancers. It tends to occur in young women and girls, and has a better prognosis than other ovarian tumors. | |||
**'''Mixed''' [[tumor]]<nowiki/>s, containing elements of more than one tumor histology | |||
*Ovarian cancer often is '''primary''', but can also be '''secondary''', the result of [[metastasis]] from a primary cancer elsewhere in the body. For example, from [[breast cancer]], or from [[gastrointestinal cancer]] (in which case the ovarian cancer is a [[Krukenberg cancer]]). Surface epithelial-stromal tumor can originate in the lining of the abdominal cavity, in which case the ovarian cancer is secondary to [[primary peritoneal cancer]], but treatment is basically the same as for primary ovarian cancer of this type. <ref name="pmid11385772" /><ref name="pmid21340753" /><ref name="pmid12644542" /><ref name="pmid15644779" /><ref name="pmid12733128" /><ref name="pmid15502809" /> | |||
Ovarian cancer | {| style="border: 0px; font-size: 90%; margin: 4px;" align="center" | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF| Ovarian cancer Types}} | |||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF| Ovarian cancer subtypes }} | |||
|- | |||
| rowspan="20;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |[[Surface epithelial-stromal tumour]] (60-70%) | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Ovarian serous tumor | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*[[Ovarian serous cystadenoma]]: ~60% of serous tumor | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Ovarian borderline serous cystadenoma: ~15% of serous tumor | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Ovarian serous cystadenocarcinoma: ~25% of serous tumor; commonest malignant ovarian tumour | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Ovarian mucinous tumor | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Ovarian mucinous cystadenoma: ~80% of mucinous tumor | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Ovarian borderline mucinous cystadenoma: 10-15% of mucinous tumor | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Ovarian mucinous cystadenocarcinoma: ~5-10% of serous tumor | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Ovarian endometrioid tumour | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* 8-15% of all ovarian tumor | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Brenner tumour | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* ~2.5% of ovarian epithelial neoplasms | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Squamous cell carcinoma of the ovary | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* ~5% of ovarian cancer | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Ovarian cystadenofibroma / ovarian adenofibroma | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* can be serous, mucinous, endometrioid, clear cell or mixed | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Ovarian cystadenocarcinofibroma | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* extremely rare | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Undifferentiated carcinoma of the ovary | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* ~4% of all ovarian tumor | |||
|- | |||
| rowspan="15;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | Germ cell ovarian tumor (~20%) | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Ovarian teratoma: commonest primary benign tumour of ovary | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Immature ovarian teratoma | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Mature ovarian (cystic) teratoma | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Specialised teratomas of the ovary | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Struma ovarii tumour | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Ovarian carcinoid tumor | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Ovarian dysgerminoma | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Ovarian yolk sac tumour | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* endodermal sinus tumour | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Ovarian embryonal carcinoma | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Ovarian choriocarcinoma | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* <1% of ovarian tumor | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Pure primary ovarian choriocarcinoma | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* extremely rare | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Malignant mixed germ cell tumour of the ovary | |||
|- | |||
| rowspan="12;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | Sex cord / stromal ovarian tumor (8-10%)<ref name="pmid12733128">{{cite journal| author=Chen VW, Ruiz B, Killeen JL, Coté TR, Wu XC, Correa CN| title=Pathology and classification of ovarian tumors. | journal=Cancer | year= 2003 | volume= 97 | issue= 10 Suppl | pages= 2631-42 | pmid=12733128 | doi=10.1002/cncr.11345 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12733128 }} </ref><ref name="pmid15502809">{{cite journal| author=Young RH| title=Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. | journal=Mod Pathol | year= 2005 | volume= 18 Suppl 2 | issue= | pages= S81-98 | pmid=15502809 | doi=10.1038/modpathol.3800311 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15502809 }} </ref> | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Ovarian fibrothecoma | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* ~5% of ovarian tumor | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Ovarian fibroma | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* ~4% of ovarian tumor | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Sclerosing stromal tumour of the ovary | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* rare | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Ovarian Sertoli-Leydig cell tumour - ovarian androblastoma | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* ~0.5% of ovarian tumor | |||
|- | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Granulosa cell tumour of ovary | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* commonest malignant sex cord tumour | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Juvenile granulosa cell tumour of ovary | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Adult granulosa cell tumour of ovary | |||
|- | |||
| rowspan="3;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |[[Others]] | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Ovarian carcinosarcoma <1% | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Primary ovarian lymphoma | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Secondary involvement of the ovary with lymphoma | |||
|- | |||
| rowspan="2;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |[[Metastases to the ovary]] | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Krukenburg tumour | |||
|- | |||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Other metastatic lesions to ovary | |||
|- | |||
|} | |||
:*[[Category:Up-To-Date]] [[Category:Oncology]] [[Category:Medicine]] [[Category:Gynecology]] [[Category:Surgery]] | |||
:* | |||
: | |||
: | |||
: | |||
: | |||
==References== | ==References== |
Latest revision as of 16:55, 4 September 2019
https://https://www.youtube.com/watch?v=h8WqX5VQP88%7C350}} |
Ovarian cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ovarian cancer classification On the Web |
American Roentgen Ray Society Images of Ovarian cancer classification |
Risk calculators and risk factors for Ovarian cancer classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.
Overview
Ovarian cancer may be classified according to the histology of the tumor, obtained in a pathology report. Based on the classification, the management of ovarian cancer is directed and determined. The main four types of ovarian cancer are Surface epithelial-stromal tumour, Sex cord-stromal tumor, Germ cell tumor, and Mixed tumors.
Classification
- Histology dictates many aspects of clinical treatment, management, and prognosis.[1][2][3][4]
- Surface epithelial-stromal tumor, including serous and mucinous cystadenocarcinoma, is the most common type of ovarian cancer.
- Sex cord-stromal tumor, including estrogen-producing granulosa cell tumor and virilizing Sertoli-Leydig cell tumor or arrhenoblastoma, accounts for 8% of ovarian cancers.
- Germ cell tumor accounts for approximately 5% of ovarian cancers. It tends to occur in young women and girls, and has a better prognosis than other ovarian tumors.
- Mixed tumors, containing elements of more than one tumor histology
- Ovarian cancer often is primary, but can also be secondary, the result of metastasis from a primary cancer elsewhere in the body. For example, from breast cancer, or from gastrointestinal cancer (in which case the ovarian cancer is a Krukenberg cancer). Surface epithelial-stromal tumor can originate in the lining of the abdominal cavity, in which case the ovarian cancer is secondary to primary peritoneal cancer, but treatment is basically the same as for primary ovarian cancer of this type. [1][2][3][4][5][6]
Ovarian cancer Types | Ovarian cancer subtypes |
---|---|
Surface epithelial-stromal tumour (60-70%) | Ovarian serous tumor |
| |
| |
| |
Ovarian mucinous tumor | |
| |
| |
| |
Ovarian endometrioid tumour | |
| |
Brenner tumour | |
| |
Squamous cell carcinoma of the ovary | |
| |
Ovarian cystadenofibroma / ovarian adenofibroma | |
| |
Ovarian cystadenocarcinofibroma | |
| |
Undifferentiated carcinoma of the ovary | |
| |
Germ cell ovarian tumor (~20%) | Ovarian teratoma: commonest primary benign tumour of ovary |
| |
| |
| |
| |
| |
Ovarian dysgerminoma | |
Ovarian yolk sac tumour | |
| |
Ovarian embryonal carcinoma | |
Ovarian choriocarcinoma | |
| |
Pure primary ovarian choriocarcinoma | |
| |
Malignant mixed germ cell tumour of the ovary | |
Sex cord / stromal ovarian tumor (8-10%)[5][6] | Ovarian fibrothecoma |
| |
Ovarian fibroma | |
| |
Sclerosing stromal tumour of the ovary | |
| |
Ovarian Sertoli-Leydig cell tumour - ovarian androblastoma | |
| |
Granulosa cell tumour of ovary | |
| |
Juvenile granulosa cell tumour of ovary | |
Adult granulosa cell tumour of ovary | |
Others | Ovarian carcinosarcoma <1% |
| |
| |
Metastases to the ovary | Krukenburg tumour |
Other metastatic lesions to ovary |
References
- ↑ 1.0 1.1 Heintz AP, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman WT; et al. (2001). "Carcinoma of the ovary". J Epidemiol Biostat. 6 (1): 107–38. PMID 11385772.
- ↑ 2.0 2.1 Banks E (2001). "The epidemiology of ovarian cancer". Methods Mol Med. 39: 3–11. doi:10.1385/1-59259-071-3:3. PMID 21340753.
- ↑ 3.0 3.1 Singer G, Oldt R, Cohen Y, Wang BG, Sidransky D, Kurman RJ; et al. (2003). "Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma". J Natl Cancer Inst. 95 (6): 484–6. doi:10.1093/jnci/95.6.484. PMID 12644542.
- ↑ 4.0 4.1 Singer G, Stöhr R, Cope L, Dehari R, Hartmann A, Cao DF; et al. (2005). "Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation". Am J Surg Pathol. 29 (2): 218–24. PMID 15644779.
- ↑ 5.0 5.1 Chen VW, Ruiz B, Killeen JL, Coté TR, Wu XC, Correa CN (2003). "Pathology and classification of ovarian tumors". Cancer. 97 (10 Suppl): 2631–42. doi:10.1002/cncr.11345. PMID 12733128.
- ↑ 6.0 6.1 Young RH (2005). "Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems". Mod Pathol. 18 Suppl 2: S81–98. doi:10.1038/modpathol.3800311. PMID 15502809.